Aarkstore - Blepharitis - Pipeline Review, H1 2015

1
Aarkstore - Blepharitis - Pipeline Review, H1 2015
www.aarkstore.com
2
Summary

• Global Markets Directs, Blepharitis - Pipeline
  Review, H1 2015, provides an overview
• of the Blepharitiss therapeutic pipeline.
•  
• This Market Research Report provides
  comprehensive information on the therapeutic
• development for Blepharitis, complete with
  comparative analysis at various stages,
• therapeutics assessment by drug target, mechanism
  of action (MoA), route of administration
• (RoA) and molecule type, along with latest
  updates, and featured news and press releases. It
• also reviews key players involved in the
  therapeutic development for Blepharitis and
  special
• features on late-stage and discontinued projects.

www.aarkstore.com
3
Scope

• - The report provides a snapshot of the global
  therapeutic landscape of Blepharitis
• - The report reviews key pipeline products under
  drug profile section which includes, product
  description, MoA and RD brief, licensing and
  collaboration details other developmental
  activities
• - The report reviews key players involved in the
  therapeutics development for Blepharitis and
  enlists all their major and minor projects
• - The report summarizes all the dormant and
  discontinued pipeline projects
• - A review of the Blepharitis products under
  development by companies and universities/research
  institutes based on information derived from
  company and industry-specific sources
• - Pipeline products coverage based on various
  stages of development ranging from
  pre-registration till discovery and undisclosed
  stages
• - A detailed assessment of monotherapy and
  combination therapy pipeline projects
• - Coverage of the Blepharitis pipeline on the
  basis of target, MoA, route of administration and
  molecule type

www.aarkstore.com
4
Reasons to buy

• - Provides strategically significant competitor
  information, analysis, and insights to formulate
  effective RD development strategies
• - Identify emerging players with potentially
  strong product portfolio and create effective
  counter-strategies to gain competitive advantage
• - Develop strategic initiatives by understanding
  the focus areas of leading companies
• - Identify and understand important and diverse
  types of therapeutics under development for
  Blepharitis
• - Plan mergers and acquisitions effectively by
  identifying key players of the most promising
  pipeline
• - Devise corrective measures for pipeline
  projects by understanding Blepharitis pipeline
  depth and focus of Indication therapeutics
• - Develop and design in-licensing and
  out-licensing strategies by identifying
  prospective partners with the most attractive
  projects to enhance and expand business potential
  and Scope

www.aarkstore.com
5
Table of Contents

• Introduction 5
• Global Markets Direct Report Coverage 5
• Blepharitis Overview 6
• Therapeutics Development 7
• Pipeline Products for Blepharitis - Overview 7
• Pipeline Products for Blepharitis - Comparative
  Analysis 8
• Blepharitis - Therapeutics under Development by
  Companies 9
• Blepharitis - Pipeline Products Glance 10

www.aarkstore.com
6
List Of Tables

• Number of Products under Development for
  Blepharitis, H1 2015 7
• Number of Products under Development for
  Blepharitis - Comparative Analysis, H1 2015 8
• Number of Products under Development by
  Companies, H1 2015 9
• Comparative Analysis by Late Stage Development,
  H1 2015 10
• Comparative Analysis by Clinical Stage
  Development, H1 2015 11
• Comparative Analysis by Early Stage Development,
  H1 2015 12
• Comparative Analysis by Unknown Stage
  Development, H1 2015 13
• Products under Development by Companies, H1 2015
  14

www.aarkstore.com
7
List Of Figures

• Number of Products under Development for
  Blepharitis, H1 2015 7
• Number of Products under Development for
  Blepharitis - Comparative Analysis, H1 2015 8
• Number of Products under Development by
  Companies, H1 2015 9
• Assessment by Monotherapy Products, H1 2015 19
• Number of Products by Top 10 Targets, H1 2015 21
• Number of Products by Stage and Top 10 Targets,
  H1 2015 22
• Number of Products by Top 10 Mechanism of
  Actions, H1 2015 23
• Number of Products by Stage and Top 10 Mechanism
  of Actions, H1 2015 24
• Number of Products by Top 10 Routes of
  Administration, H1 2015 25

www.aarkstore.com
8
Related Market Research reports

• Ocular Hypertension - Pipeline Review, H1 2015
• Transitional Cell Cancer (Urothelial Cell Cancer)
  - Pipeline Review, H1 2015
• Actinic (Solar) Keratosis - Pipeline Review, H1
  2015
• Allergic Rhino-Conjunctivitis - Pipeline Review,
  H1 2015
• Severe Acute Respiratory Syndrome (SARS)
  Coronavirus Infection - Pipeline Review, H1 2015

www.aarkstore.com
9
Related Market Research reports

• Myocardial Ischemia - Pipeline Review, H1 2015
• Thalassemia - Pipeline Review, H1 2015
• Encephalomyelitis - Pipeline Review, H1 2015
• T-Cell Leukemia - Pipeline Review, H1 2015
• Peripheral T-Cell Lymphomas (PTCL) - Pipeline
  Review, H1 2015

www.aarkstore.com
10
Aarkstore - Blepharitis - Pipeline Review, H1 2015
Format Price
PDF 2000
Site Licence 4000
Enterprise Wide Licence  6000
www.aarkstore.com
11
Contact Us

• Office
• Office No. - 809, 8th Floor,
• B-Wing, Mahaavir Icon, 
• Plot No.- 89 90, Sector-15,
• CBD-Belapur, Navi Mumbai 400614, 
• Maharashtra, India.
• 24/7 Online Support 91 9987295242
• General Inquiries 91 - 22 2756 4953
• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog http//www.aarkstore.com/blog/
• Conference http//conference.aarkstore.com/
• News http//www.aarkstore.com/news

www.aarkstore.com